Treatment of chronic hepatitis C regiments containing with recombinant interferon in patients with sustained virological response predicts risk of hepatocellular carcinoma: A meta-analysis

Given that evidence supporting chronic hepatitis C (CHC) infection developed chance for hepatocellular carcinoma (HCC) following antiviral agents therapy is controversial. We conducted a meta-analysis to examine the risk. We evaluated 20 retrospective and prospective cohort studies published up to 3...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Chien-Feng, Tsao, Shih-Ming, Liao, Hsien-Hua, Chen, Shiuan-Chih, Lee, Yuan-Ti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
4900
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7535677/
https://www.ncbi.nlm.nih.gov/pubmed/33019424
http://dx.doi.org/10.1097/MD.0000000000022435

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7535677/
https://www.ncbi.nlm.nih.gov/pubmed/33019424
http://dx.doi.org/10.1097/MD.0000000000022435

Ejemplares similares